Evidence map›Paper›PMID 40723467›Full record

ArticleAnimals : an open access journal from MDPI2025

Glycated Albumin and Continuous Glucose Monitoring Metrics in Dogs with Diabetes Mellitus: A Pilot Study.

Soon-Chan Kwon, Ju-Hyun An, Dong-Hoo Kim, Hwa-Young Youn

Abstract read
In one paragraph

Article in Animals : an open access journal from MDPI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Soon-Chan KwonLaboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, Seoul-si 08826, Republic of Korea.
Ju-Hyun AnDepartment of Veterinary Emergency and Critical Care Medicine, College of Veterinary Medicine, Kangwon National University, Chuncheon-si 24341, Republic of Korea.ORCID 0000-0002-3756-9482
Dong-Hoo KimGogang Animal Hospital, Bucheon-si 14408, Republic of Korea.
Hwa-Young YounLaboratory of Veterinary Internal Medicine, Department of Veterinary Clinical Science, College of Veterinary Medicine, Seoul National University, Seoul-si 08826, Republic of Korea.

Funding

2024 Research Grant from Kangwon National University non grant numberthe National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) RS-2023-00240708
6 · The paper itself

Abstract

Diabetes mellitus (DM) is one of the most common endocrine disorders in dogs. Glycated albumin (GA), a biomarker of short-term glycemia, may offer a valuable tool for assessing glycemic control in dogs with DM. This pilot study evaluated the correlation between GA and conventional glycemic markers and continuous glucose monitoring (CGM)-derived metrics in dogs. A total of 30 dogs were included in this prospective pilot study, comprising dogs with diabetes mellitus (n = 10) and healthy controls (n = 20). Of these, 11 dogs that lacked anemia, hypoalbuminemia, or azotemia and whose owners consented to 14-day CGM were analyzed for sensor-based metrics (dogs with diabetes, n = 7; controls, n = 4). Across the full cohort, GA showed significant correlations with fructosamine and HbA1c, while within the CGM subset, GA was significantly associated with mean glucose level, TIR2, and TAR2. These findings suggest that GA, in conjunction with fructosamine and HbA1c, offers valuable insights into glycemic control over a 2-week period and could serve as a reliable biomarker for glucose monitoring in dogs with diabetes.

Indexed as

continuous glucose monitoring systemdiabetic mellitusdogglycated albumin

Identifiers

PMID40723467
PMCPMC12291857

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.